EU-Mercosur Trade Agreement: A bad deal for transparency, policy coherence and access to medicines

Meet Callum Gunn: Our #InvaluableIntern & Rising TTIP Afficionado


HAI urges MEPs to support key amendments to TTIP resolution

The EU-US Trade Deal Could Leave Europeans Sick

World Health Assembly Executive Board 136: YP-CDN and HAI intervention on the progress achieved in the prevention and control of non-communicable diseases


Student Stop AIDS National Gathering an inspiring start to Access to Medicines Week

Democracy violation: European Commission rejects citizens’ initiative to stop TTIP and CETA

Leaks and Lies: Pharma’s strategy to derail South Africa’s intellectual property reforms exposed


When politicians go to the movies

Good week for access to affordable medicines


Public Event on EU-MERCOSUR in Buenos Aires

DG Trade State of Play reveals EU's ambitions for IP protection in FTAs

DG Trade public hearing on the “Protection and enforcement of IPR in third countries

EU-Mercosur Trade Negotiations: What Fate for Access to medicines?


ACTA, Democracy & Access to Medicines

Doha Declaration Par 6 to be reviewed in TRIPS Council

Welfare Implications of Intellectual Property Enforcement

Report exposes how Big Pharma has hijacked EU-India trade deal

International Experts Find that Pending Anti-Counterfeiting Trade Agreement Threatens Public Interests

Innovation & Access at the EU High Level Event on Global Health

Quito Declaration

Quito Declaration

HAI hosts essay competition for students

EU-India negotiations on FTA pose a serious threat to access to affordable medicines in the developing world

LAC-EU Alliance for Access to Medicines welcomes compulsory license by Ecuadorian Government

Where to find ACTA Draft Negotiating Text

EU Global Health Communication

HAI Response: ACTA Stakeholders Meeting in European Parliament